EMBCEmbecta Corp.
$3.35-66% 1Y
$3.35
$2.8952 weeks$14.20
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Price is −16% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How EMBC is trading
Embecta Corp. is −66% over the past year while the S&P 500 is +18%: 84 points behind the market.
−66%
1-year return · S&P 500 +18%
- vs 200-day average
- −16%
vs 200-day average · a clear downtrend
- RSI (14)
- 64
RSI (14) · neutral
- Below its 52-week high
- 59%
Below its 52-week high
Details›
- Last close2026-10-08
- $3.35
- 1 monthS&P 500 +1.6%
- −4.0%
- 1 yearS&P 500 +18%
- −66%
- vs 50-day average$5.14
- +12%
- 52-week high
- $14.20
- 52-week low
- $2.89
- Annualised volatility
- 72%
| Year | Return |
|---|---|
| 2026 (year to date) | −51% |
| 2025 | −40% |
| 2024 | +14% |
| 2023 | −23% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −7.2% |
| Feb | 4 | 1 of 4 | −5.0% |
| Mar | 4 | 0 of 4 | −9.6% |
| Apr | 5 | 1 of 5 | −6.9% |
| May | 5 | 2 of 5 | −14% |
| Jun | 5 | 2 of 5 | −6.0% |
| Jul | 5 | 4 of 5 | +11% |
| Aug | 5 | 4 of 5 | +17% |
| Sep | 5 | 1 of 5 | −6.8% |
| Oct | 5 | 3 of 5 | +0.82% |
| Nov | 4 | 3 of 4 | +18% |
| Dec | 4 | 1 of 4 | −6.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #3 of 21 by RyuScore